These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18481434)

  • 1. [alpha1-adrenoceptor antagonists and ejaculation dysfunction].
    Chen Y; Li H; Dong Q
    Zhonghua Nan Ke Xue; 2008 Apr; 14(4):364-7. PubMed ID: 18481434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1-adrenoceptors are required for normal male sexual function.
    Sanbe A; Tanaka Y; Fujiwara Y; Tsumura H; Yamauchi J; Cotecchia S; Koike K; Tsujimoto G; Tanoue A
    Br J Pharmacol; 2007 Oct; 152(3):332-40. PubMed ID: 17603545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction.
    Rosen RC; Catania JA; Althof SE; Pollack LM; O'Leary M; Seftel AD; Coon DW
    Urology; 2007 May; 69(5):805-9. PubMed ID: 17482908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission.
    Hisasue S; Furuya R; Itoh N; Kobayashi K; Furuya S; Tsukamoto T
    Int J Urol; 2006 Oct; 13(10):1311-6. PubMed ID: 17010010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of doxazosin on sexual function in patients with benign prostatic hyperplasia, hypertension, or both.
    Flack JM
    Int J Clin Pract; 2002 Sep; 56(7):527-30. PubMed ID: 12296615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Djavan B; Chapple C; Milani S; Marberger M
    Urology; 2004 Dec; 64(6):1081-8. PubMed ID: 15596173
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha1-adrenoceptors and ejaculatory function.
    Michel MC
    Br J Pharmacol; 2007 Oct; 152(3):289-90. PubMed ID: 17603543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system.
    Andersson KE; Gratzke C
    Nat Clin Pract Urol; 2007 Jul; 4(7):368-78. PubMed ID: 17615548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ejaculatory dysfunction and its association with lower urinary tract symptoms of benign prostatic hyperplasia and BPH treatment.
    Hellstrom WJ; Giuliano F; Rosen RC
    Urology; 2009 Jul; 74(1):15-21. PubMed ID: 19428091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common approach to managing lower urinary tract symptoms and erectile dysfunction.
    Taylor JM; Desouza R; Wang R
    Asian J Androl; 2008 Jan; 10(1):45-53. PubMed ID: 18087643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of alpha1-adrenoceptor subtypes in benign prostatic hyperplasia-from bed to bench].
    Kojima Y; Hayase M; Imura M; Okada S; Kubota Y; Sasaki S; Hayashi Y; Kohri K
    Hinyokika Kiyo; 2008 Jun; 54(6):457-62. PubMed ID: 18634446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of alpha 1A-adrenoceptor: a novel possible strategy for male contraception.
    Chen Y; Li H; Dong Q; Wang KJ
    Med Hypotheses; 2009 Aug; 73(2):140-1. PubMed ID: 19427736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers.
    Hellstrom WJ; Sikka SC
    J Urol; 2006 Oct; 176(4 Pt 1):1529-33. PubMed ID: 16952675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study.
    Masumori N; Tsukamoto T; Iwasawa A; Furuya R; Sonoda T; Mori M;
    Urol Int; 2009; 83(1):49-54. PubMed ID: 19641359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking?
    Sturch P; Woo HH; McNicholas T; Muir G
    BJU Int; 2015 Feb; 115(2):186-7. PubMed ID: 25046575
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of alpha(1)-adrenoceptor antagonists on male sexual function.
    van Dijk MM; de la Rosette JJ; Michel MC
    Drugs; 2006; 66(3):287-301. PubMed ID: 16526818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds.
    Wong P; Lawrentschuk N; Bolton DM
    Curr Opin Urol; 2009 Jan; 19(1):7-12. PubMed ID: 19057210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ejaculatory dysfunction and depression: pharmacological and psychobiological interactions.
    Seidman S
    Int J Impot Res; 2006; 18 Suppl 1():S33-8. PubMed ID: 16953246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual Side Effects of Medical and Surgical Benign Prostatic Hyperplasia Treatments.
    Welliver C; Essa A
    Urol Clin North Am; 2016 Aug; 43(3):393-404. PubMed ID: 27476132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age related changes in the functional, biochemical and molecular properties of alpha1-adrenoceptors in the rat genitourinary tract.
    Yono M; Foster HE; Weiss RM; Latifpour J
    J Urol; 2006 Sep; 176(3):1214-9. PubMed ID: 16890728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.